{"database": "openregs", "table": "documents", "rows": [["FDA-2001-E-0027-0020", "FDA", "FDA-2001-E-0027", "Determinations of Regulatory Review Periods for Purposes of Patent Extensions: ANGIOMAX", "Notice", "N-Notice", "2010-12-16T05:00:00Z", 2010, 12, "2010-12-16T05:00:00Z", null, "2024-11-12T05:00:23Z", "2010-31583", 1, 0, "0900006480bb825a"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2001-E-0027-0020"], "units": {}, "query_ms": 0.5114709492772818, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}